Structure of the primed paramyxovirus fusion protein.
Structure of the primed paramyxovirus fusion protein.
复制标题
引发的副粘病毒融合蛋白的结构。
DOI:
10.1073/pnas.1214903109
复制
发表时间:
2012
影响因子:
11.1
通讯作者:
Plemper,RichardKarl
中科院分区:
文献类型:
--
作者:
Steinhauer,DavidA;Plemper,RichardKarl
Viruses with lipid envelopes must fuse their membranes with those of host cells to transfer their genomes and initiate infection. Depending on the virus, the membrane fusion process can occur at the plasma membrane, or at intracellular membranes following the internalization of virus particles. Not surprisingly, the viral proteins responsible for membrane fusion are highly diverse, as are the mechanisms by which the fusion processes can be triggered; however, common themes have emerged as our understanding of membrane fusion has developed. In particular, an expanding repertoire of high-resolution structures of viral fusion proteins (F proteins; VFPs) in pre-and postfusion conformations has driven the field forward. From these, we know that many VFPs undergo substantial conformational changes during fusion, forming highly stable rod-like structures to draw the membranes together (1–3). Despite this, for VFPs other than influenza HA (4–7), highresolution structures for all three major static conformations adopted during the virus life cycle, uncleaved prefusion, primed prefusion and postfusion, have remained incomplete. These limitations have hindered our development of insights into the fusion mechanism of viruses that, unlike influenza virus, enter cells at the plasma membrane at neutral pH. In a groundbreaking report in PNAS (8), Welch et al. solve the high-resolution X-ray crystal structure of the cleaved, prefusion form of the F protein of parainfluenza virus 5 (PIV5). This alters the state of affairs by providing an essential missing link in the understanding of paramyxovirus entry. In conjunction with previous work by these laboratories (9, 10), the new structure now affords us with a complete set of all three major static conformations of paramyxovirus F proteins (Fig. 1), a tour de force representing many years of effort (9, 10). This constitutes another fundamental building block on which we can establish a broader appreciation of how different viruses prime their surface glycoproteins to mediate cell entry and initiate infection. In addition to advancing our molecular knowledge of virus biology, the present achievement will further the educated development of antiviral drugs designed to inhibit membrane fusion. During the past decade, the expansion of our structural and mechanistic understanding of VFPs has allowed for their grouping into type I, II, and III classes (11, 12). We focus here on the type I VFPs that include influenza HA and paramyxovirus F proteins, as well as VFPs of other major human pathogens such as HIV Env and Ebola virus GP. Hallmarks of type I VFPs include initial synthesis and folding into an oligomeric precursor structure, which requires proteolytic processing into a mature form to prime the membrane fusion potential and virus infectivity (13–16). Each monomer is cleaved directly adjacent to an internal hydrophobic domain, the “fusion peptide,” which then forms the newly liberated N-terminal section of the membrane-anchored subunit. When it has been activated by proteolysis, the prefusion conformations must be triggered by external stimuli such as engagement of a cellular receptor in the case of paramyxoviruses, or the acidic environment of an endosome as found with influenza, to undergo the extensive structural rearrangements that drive the membrane fusion process (Fig. 1). Therefore, over the course of the virus replication cycle, the F proteins adopt at least three distinct static conformations, which are, along with the transitions from one structure to the next, critical for virus entry. The structural rearrangements that accompany cleavage activation of influenza HA are revealing with regard to the subsequent triggering of fusion …